Recently, peroxisome proliferator-activated receptor gamma (PPAR-γ) modulator, GED-0507-34 Levo, reduced EMT progression by reducing EMT-related genes in chronic colitis-associated fibrosis animal models (Di Gregorio et al., 2017). This evidence concerns the gene PPARG and fibrosis.